Pathogenic Fungi book review
I am pleased to provide the following excerpt from a book review of Pathogenic Fungi: Insights in Molecular Biology:
"The authors present a succinct review of new information on fungal pathogenicity. This new volume on the current research on fungal pathogens is a valuable resource for both scientists and clinicians. These discoveries will clearly lead to new drug discoveries and therapeutic tests that will save the lives of many patients." from Rebecca T. Horvat (University of Kansas Medical Center, USA) writing in Shock (2008) 30: 753. read more ...
"The authors present a succinct review of new information on fungal pathogenicity. This new volume on the current research on fungal pathogens is a valuable resource for both scientists and clinicians. These discoveries will clearly lead to new drug discoveries and therapeutic tests that will save the lives of many patients." from Rebecca T. Horvat (University of Kansas Medical Center, USA) writing in Shock (2008) 30: 753. read more ...
 | Edited by: Gioconda San-Blas and Richard A. Calderone a valuable resourceISBN: 978-1-904455-32-5 Publisher: Caister Academic Press Publication Date: July 2008 Cover: hardback |
Glycoconjugate Vaccines
New Frontiers in the Chemistry of Glycoconjugate Vaccines
from David R. Bundle writing in Vaccine Design: Innovative Approaches and Novel Strategies
Methods for single point attachment of polysaccharides and oligosaccharides to protein carriers and T-cell peptides are important in vaccine design. Contemporary approaches involve synthetic oligosaccharides with linker or tether chemistry designed for compatibility with synthetic strategies. Current research involves the synthesis and evaluation of conjugate vaccines designed to combat infectious bacterial and fungal diseases, as well as the design and testing of therapeutic cancer vaccine. The prevailing dogma that protective B-cell epitopes should be comprised of 10-20 monosaccharides is confirmed for several experimental vaccines including those directed toward Shigell flexneri and Shigella dysenteriae. However, several small epitopes composed of 3-5 monosaccharide residues are sufficient to induce antibody against the whole organism and to confer protection.
Further reading: Vaccine Design: Innovative Approaches and Novel Strategies
from David R. Bundle writing in Vaccine Design: Innovative Approaches and Novel Strategies
Methods for single point attachment of polysaccharides and oligosaccharides to protein carriers and T-cell peptides are important in vaccine design. Contemporary approaches involve synthetic oligosaccharides with linker or tether chemistry designed for compatibility with synthetic strategies. Current research involves the synthesis and evaluation of conjugate vaccines designed to combat infectious bacterial and fungal diseases, as well as the design and testing of therapeutic cancer vaccine. The prevailing dogma that protective B-cell epitopes should be comprised of 10-20 monosaccharides is confirmed for several experimental vaccines including those directed toward Shigell flexneri and Shigella dysenteriae. However, several small epitopes composed of 3-5 monosaccharide residues are sufficient to induce antibody against the whole organism and to confer protection.
Further reading: Vaccine Design: Innovative Approaches and Novel Strategies
Aspergillus book review
I am pleased to provide the following excerpt from a book review of Aspergillus: Molecular Biology and Genomics:
"a readable but authoritive overview of current knowledge and approaches ... Its approach is firmly post-genomic, emphasizing the new insights that can be gained ... This book will be a good institutional purchase to support advanced teaching but also for personal or laboratory purchase for researchers within industry." from Meriel G. Jones (University of Liverpool, UK) writing in Microbiology Today read more ...
"a readable but authoritive overview of current knowledge and approaches ... Its approach is firmly post-genomic, emphasizing the new insights that can be gained ... This book will be a good institutional purchase to support advanced teaching but also for personal or laboratory purchase for researchers within industry." from Meriel G. Jones (University of Liverpool, UK) writing in Microbiology Today read more ...
 | Edited by: Masayuki Machida and Katsuya Gomi "authoritive overview" (Microbiology Today)ISBN: 978-1-904455-53-0 Publisher: Caister Academic Press Publication Date: January 2010 Cover: hardback |